MacroGenics, Inc. (MGNX)
3.74
+0.19
(+5.35%)
USD |
NASDAQ |
Oct 09, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Market Cap : 238.03M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 238.03M |
| October 08, 2026 | 225.94M |
| October 07, 2026 | 225.94M |
| October 06, 2026 | 231.67M |
| October 05, 2026 | 239.94M |
| October 02, 2026 | 227.85M |
| October 01, 2026 | 229.12M |
| September 30, 2026 | 245.67M |
| September 29, 2026 | 239.94M |
| September 28, 2026 | 258.40M |
| September 25, 2026 | 238.03M |
| September 24, 2026 | 241.85M |
| September 23, 2026 | 241.85M |
| September 22, 2026 | 262.22M |
| September 21, 2026 | 262.22M |
| September 18, 2026 | 263.49M |
| September 17, 2026 | 262.86M |
| September 16, 2026 | 259.67M |
| September 15, 2026 | 257.13M |
| September 14, 2026 | 267.31M |
| September 11, 2026 | 254.58M |
| September 10, 2026 | 252.67M |
| September 09, 2026 | 261.58M |
| September 08, 2026 | 274.95M |
| September 04, 2026 | 280.04M |
| Date | Value |
|---|---|
| September 03, 2026 | 270.49M |
| September 02, 2026 | 274.95M |
| September 01, 2026 | 257.13M |
| August 31, 2026 | 253.95M |
| August 28, 2026 | 262.86M |
| August 27, 2026 | 259.67M |
| August 26, 2026 | 257.13M |
| August 25, 2026 | 265.40M |
| August 24, 2026 | 255.86M |
| August 21, 2026 | 260.95M |
| August 20, 2026 | 259.04M |
| August 19, 2026 | 265.40M |
| August 18, 2026 | 260.31M |
| August 17, 2026 | 258.40M |
| August 14, 2026 | 268.58M |
| August 13, 2026 | 259.67M |
| August 12, 2026 | 255.86M |
| August 11, 2026 | 249.49M |
| August 10, 2026 | 259.67M |
| August 07, 2026 | 256.78M |
| August 06, 2026 | 254.88M |
| August 05, 2026 | 247.88M |
| August 04, 2026 | 247.88M |
| August 03, 2026 | 242.80M |
| July 31, 2026 | 234.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 187.60B |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
Market Cap Related Metrics
| PS Ratio | 1.414 |
| Price to Book Value | 5.552 |
| Price | 3.74 |
| Earnings Yield | -6.16% |